273 related articles for article (PubMed ID: 31069270)
1. Co-expression of Cas9 and single-guided RNAs in
Qiao J; Li W; Lin S; Sun W; Ma L; Liu Y
Commun Biol; 2019; 2():161. PubMed ID: 31069270
[TBL] [Abstract][Full Text] [Related]
2. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
Shin HR; Kweon J; Kim Y
Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
[TBL] [Abstract][Full Text] [Related]
3. A Survey of Genome Editing Activity for 16 Cas12a Orthologs.
Zetsche B; Abudayyeh OO; Gootenberg JS; Scott DA; Zhang F
Keio J Med; 2020 Sep; 69(3):59-65. PubMed ID: 31723075
[TBL] [Abstract][Full Text] [Related]
4. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.
Swartjes T; Staals RHJ; van der Oost J
Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209
[TBL] [Abstract][Full Text] [Related]
5. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
[TBL] [Abstract][Full Text] [Related]
6. Expanding the scope of plant genome engineering with Cas12a orthologs and highly multiplexable editing systems.
Zhang Y; Ren Q; Tang X; Liu S; Malzahn AA; Zhou J; Wang J; Yin D; Pan C; Yuan M; Huang L; Yang H; Zhao Y; Fang Q; Zheng X; Tian L; Cheng Y; Le Y; McCoy B; Franklin L; Selengut JD; Mount SM; Que Q; Zhang Y; Qi Y
Nat Commun; 2021 Mar; 12(1):1944. PubMed ID: 33782402
[TBL] [Abstract][Full Text] [Related]
7. Multiplexed conditional genome editing with Cas12a in
Port F; Starostecka M; Boutros M
Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22890-22899. PubMed ID: 32843348
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas12 and Cas13: the lesser known siblings of CRISPR-Cas9.
Yan F; Wang W; Zhang J
Cell Biol Toxicol; 2019 Dec; 35(6):489-492. PubMed ID: 31468291
[No Abstract] [Full Text] [Related]
9. Genome editing via delivery of Cas9 ribonucleoprotein.
DeWitt MA; Corn JE; Carroll D
Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976
[TBL] [Abstract][Full Text] [Related]
10. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
Berkhout B; Gao Z; Herrera-Carrillo E
Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
[TBL] [Abstract][Full Text] [Related]
11. Highly efficient DNA-free gene disruption in the agricultural pest Ceratitis capitata by CRISPR-Cas9 ribonucleoprotein complexes.
Meccariello A; Monti SM; Romanelli A; Colonna R; Primo P; Inghilterra MG; Del Corsano G; Ramaglia A; Iazzetti G; Chiarore A; Patti F; Heinze SD; Salvemini M; Lindsay H; Chiavacci E; Burger A; Robinson MD; Mosimann C; Bopp D; Saccone G
Sci Rep; 2017 Aug; 7(1):10061. PubMed ID: 28855635
[TBL] [Abstract][Full Text] [Related]
12. PEG-Delivered CRISPR-Cas9 Ribonucleoproteins System for Gene-Editing Screening of Maize Protoplasts.
Sant'Ana RRA; Caprestano CA; Nodari RO; Agapito-Tenfen SZ
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32887261
[TBL] [Abstract][Full Text] [Related]
13. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
Swarts DC; van der Oost J; Jinek M
Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
[TBL] [Abstract][Full Text] [Related]
14. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
Yang H; Patel DJ
Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
[TBL] [Abstract][Full Text] [Related]
15. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
16. Efficient Editing of the Nuclear
Guzmán-Zapata D; Sandoval-Vargas JM; Macedo-Osorio KS; Salgado-Manjarrez E; Castrejón-Flores JL; Oliver-Salvador MDC; Durán-Figueroa NV; Nogué F; Badillo-Corona JA
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871076
[TBL] [Abstract][Full Text] [Related]
17. An Efficient Expression and Purification Protocol for SpCas9 Nuclease and Evaluation of Different Delivery Methods of Ribonucleoprotein.
Evmenov K; Pustogarov N; Panteleev D; Safin A; Alkalaeva E
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338898
[TBL] [Abstract][Full Text] [Related]
18. Live-cell imaging reveals the trade-off between target search flexibility and efficiency for Cas9 and Cas12a.
Olivi L; Bagchus C; Pool V; Bekkering E; Speckner K; Offerhaus H; Wu WY; Depken M; Martens KJA; Staals RHJ; Hohlbein J
Nucleic Acids Res; 2024 May; 52(9):5241-5256. PubMed ID: 38647045
[TBL] [Abstract][Full Text] [Related]
19. PpCas9 from Pasteurella pneumotropica - a compact Type II-C Cas9 ortholog active in human cells.
Fedorova I; Vasileva A; Selkova P; Abramova M; Arseniev A; Pobegalov G; Kazalov M; Musharova O; Goryanin I; Artamonova D; Zyubko T; Shmakov S; Artamonova T; Khodorkovskii M; Severinov K
Nucleic Acids Res; 2020 Dec; 48(21):12297-12309. PubMed ID: 33152077
[TBL] [Abstract][Full Text] [Related]
20. The Expanding Class 2 CRISPR Toolbox: Diversity, Applicability, and Targeting Drawbacks.
Hajizadeh Dastjerdi A; Newman A; Burgio G
BioDrugs; 2019 Oct; 33(5):503-513. PubMed ID: 31385197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
